Benchmark Initiates Applied DNA Sciences With Speculative Buy

Analysts at Benchmark initiated coverage on
Applied DNA Sciences Inc
APDN
with a Speculative Buy rating. The target price for Applied DNA Sciences is set to $5. Applied DNA Sciences shares have dropped 61.36 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period. Applied DNA Sciences' shares rose 2.41 percent to close at $2.55 on Friday.

Posted In: BenchmarkInitiationAnalyst Ratings